Antiviral Efficacy of Coridothymus capitatus Essential Oil Against HSV-1 and HSV-2

被引:0
|
作者
Fuochi, Virginia [1 ]
Furneri, Pio Maria [1 ]
Furnari, Salvatore [1 ]
Garozzo, Adriana [1 ]
机构
[1] Univ Catania, Dipartimento Sci Biomed & Biotecnol BIOMETEC, I-95030 Catania, Italy
来源
LIFE-BASEL | 2024年 / 14卷 / 08期
关键词
Coridothymus capitatus; essential oil; carvacrol; antiviral activity; HSV-1; HSV-2; natural antiviral agents; viral replication; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; IN-VITRO; L; CAV; CARVACROL; THYMOL; ANTIBACTERIAL; WILD; POPULATIONS; SARS-COV-2;
D O I
10.3390/life14081023
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coridothymus capitatus is a perennial herb with aromatic leaves and flowers, distinct from Thymus vulgaris in its chemical composition, resulting in a unique Thymus Essential Oil (TEO). A main component of TEO, carvacrol, is known for its antimicrobial and insecticidal activity. Carvacrol has potent antibacterial, antioxidant, anti-inflammatory, and antifungal properties, generating interest in traditional medicine. However, studies on its antiviral activity are limited. Given the rise in viral infections and limitations of synthetic antiviral drugs, natural antiviral agents are promising due to their efficacy, lower resistance development, and reduced side effects. This study assessed the antiviral efficacy of TEO compared to that of pure carvacrol. We tested various viruses, revealing significant inhibitory effects of TEO on the replication of only Simplexvirus humanalpha1 (HSV-1) and Simplexvirus humanalpha2 (HSV-2), with specific interference during the early stages of the viral replication cycle after the adsorption period. TEO exhibited inhibitory effects at doses below the cytotoxic threshold, with IC50 values of 47 mu g/mL for HSV-1 and 40 mu g/mL for HSV-2. Maximum virus inhibition was achieved when TEO was added within 90 min post-infection, indicating interference with early viral replication steps. These findings highlight the potential of TEO as a natural antiviral agent and suggest further research into its mechanisms and clinical applications.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Seroprevalence of HSV-1 and HSV-2 in Barbados
    Levett, PN
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2005, 194 (1-2) : 105 - 107
  • [2] Seroprevalence of HSV-1 and HSV-2 in Barbados
    P. N. Levett
    Medical Microbiology and Immunology, 2005, 194 : 105 - 107
  • [3] Virucidal activity of a β-triketone-rich essential oil of leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture
    Reichling, J
    Koch, C
    Stahl-Biskup, E
    Sojka, C
    Schnitzler, P
    PLANTA MEDICA, 2005, 71 (12) : 1123 - 1127
  • [4] RAPID ELECTROPHORETIC DIFFERENTIATION OF HSV-1 AND HSV-2
    PYNDIAH, N
    GLAUSER, L
    DELACUISINE, B
    ANEX, JF
    EXPERIENTIA, 1982, 38 (11): : 1367 - 1367
  • [5] Molecular epidemiology of HSV-1 and HSV-2 in Germany
    Schmidt-Chanasit, J.
    Bialonski, A.
    Heinemann, P.
    Ulrich, R. G.
    Guenther, St.
    Rabenau, H. F.
    Doerr, H. W.
    HAUTARZT, 2010, 61 (02): : 174 - 175
  • [6] Worldwide circulation of HSV-2 × HSV-1 recombinant strains
    David M. Koelle
    Peter Norberg
    Matthew P. Fitzgibbon
    Ronnie M. Russell
    Alex L. Greninger
    Meei-Li Huang
    Larry Stensland
    Lichen Jing
    Amalia S. Magaret
    Kurt Diem
    Stacy Selke
    Hong Xie
    Connie Celum
    Jairam R. Lingappa
    Keith R. Jerome
    Anna Wald
    Christine Johnston
    Scientific Reports, 7
  • [7] Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis is essential oil
    De Logu, A
    Loy, G
    Pellerano, ML
    Bonsignore, L
    Schivo, ML
    ANTIVIRAL RESEARCH, 2000, 48 (03) : 177 - 185
  • [8] EFFICACY OF HSV-1 ISCOM VACCINE IN THE GUINEA-PIG MODEL OF HSV-2 INFECTION
    ERTURK, M
    PHILLPOTTS, RJ
    WELCH, MJ
    JENNINGS, R
    VACCINE, 1991, 9 (10) : 728 - 734
  • [9] Seroprevalence of HSV-1 and HSV-2 infection in the general French population
    Malkin, JE
    Morand, P
    Malvy, D
    Ly, TD
    Chanzy, B
    de Labareyre, C
    El Hasnaoui, A
    Hercberg, S
    SEXUALLY TRANSMITTED INFECTIONS, 2002, 78 (03) : 201 - 203
  • [10] EFFECTS OF PRIOR HSV-1 INFECTION ON GENITAL HSV-2 INFECTION
    BERNSTEIN, DI
    PROGRESS IN MEDICAL VIROLOGY, 1991, 38 : 109 - 127